Notice of Change to Eligibility for PAR-20-153 "NIH Science Education Partnership Award (SEPA) (R25 - Clinical Trial Not Allowed)"
Notice Number:
NOT-GM-20-031

Key Dates

Release Date: May 11, 2020

Related Announcements

Issued by

National Institute of General Medical Sciences (NIGMS)

Purpose

The purpose of this Notice is to clarify the institutional eligibility for applications submitted to PAR-20-153 "NIH Science Education Partnership Award (SEPA) (R25 - Clinical Trial Not Allowed)".

Part 2. Section III.3

Additional Information on Eligibility

The FOA currently reads:

Number of Applications

The NIH will not accept duplicate or highly overlapping applications under review at the same time. This means that the NIH will not accept:

  • A new (A0) application that is submitted before issuance of the summary statement from the review of an overlapping new (A0) or resubmission (A1) application.
  • A resubmission (A1) application that is submitted before issuance of the summary statement from the review of the previous new (A0) application.
  • An application that has substantial overlap with another application pending appeal of initial peer review (see NOT-OD-11-101)

An eligible institution, defined as a university, an independent college/institute, a museum, a hospital, or a professional society, may submit one application per due date.

An institution with an active SEPA award is ineligible to submit another SEPA application.

This section of the FOA is modified to read:

Number of Applications

The NIH will not accept duplicate or highly overlapping applications under review at the same time. This means that the NIH will not accept:

  • A new (A0) application that is submitted before issuance of the summary statement from the review of an overlapping new (A0) or resubmission (A1) application.
  • A resubmission (A1) application that is submitted before issuance of the summary statement from the review of the previous new (A0) application.
  • An application that has substantial overlap with another application pending appeal of initial peer review (see NOT-OD-11-101)

An eligible institution, defined as a university, an independent college/institute, a museum, a hospital, or a professional society, may submit one application per due date.

An institution with an active SEPA award is eligible to submit an application for a new SEPA project as long as there is no more than six months' overlapbetween the end of the current SEPA award and the start date for a new SEPA award.

All other aspects of this FOA remain the same.

Inquiries

Please direct all inquiries to:

Tony Beck, Ph.D.
National Institute of General Medical Sciences (NIGMS)
Email: [email protected]


Weekly TOC for this Announcement
NIH Funding Opportunities and Notices